CHARLES RIVER LABORATORIES (CRL) Stock Analyst Earnings Estimates
NYSE:CRL - New York Stock Exchange, Inc. - US1598641074 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.976B 12.31% | 4.129B 3.86% | 4.05B -1.92% | 3.949B -2.49% | 4.182B 5.90% | 4.738B 13.30% | 5.051B 6.61% | 5.447B 7.84% | 6.563B 20.49% | 7.251B 10.48% | 8.021B 10.62% | |
| EBITDA YoY % growth | 963.585M 7.24% | 973.446M 1.02% | 912.573M -6.25% | 982.19M 7.63% | 1.071B 9.04% | 1.23B 14.85% | 1.381B 12.28% | 1.6B 15.86% | 1.837B 14.81% | 2.074B 12.90% | 2.343B 12.97% | |
| EBIT YoY % growth | 659.715M 4.22% | 659.322M -0.06% | 550.832M -16.45% | 739.41M 34.24% | 816.06M 10.37% | 998.2M 22.32% | 1.009B 1.08% | 1.087B 7.73% | N/A | N/A | N/A | |
| Operating Margin | 16.59% | 15.97% | 13.60% | 18.72% | 19.51% | 21.07% | 19.98% | 19.96% | N/A | N/A | N/A | |
| EPS YoY % growth | 11.13 7.74% | 10.65 -4.31% | 10.32 -3.10% | 9.67 -6.32% | 10.75 11.23% | 13.03 21.17% | 13.82 6.09% | 15.20 9.94% | 26.09 71.68% | 29.52 13.16% | N/A |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 2.12 -6.58% | 2.40 -14.41% | 2.43 -6.09% | 2.54 -4.50% | 2.41 13.83% | 2.65 10.55% | 2.66 9.30% | 2.74 8.06% | 2.68 10.88% | 2.81 6.16% | 3.05 14.73% | 3.27 19.21% |
| Revenue Q2Q % growth | 953.14M -5.78% | 971.09M -5.36% | 971.41M -3.80% | 980.07M -2.24% | 998.91M 4.80% | 1.017B 4.73% | 1.02B 5.00% | 1.03B 5.09% | 1.078B 7.92% | 1.078B 6.00% | 1.112B 9.02% | 1.155B 12.14% |
| EBITDA Q2Q % growth | 233.91M 2.44% | 250.72M -26.48% | 249.63M -38.77% | 256.49M -43.25% | 252.17M 7.81% | 269.84M 7.63% | 266.68M 6.83% | 271.26M 5.76% | 286.95M 13.79% | 296.42M 9.85% | 314.62M 17.98% | 331.37M 22.16% |
| EBIT Q2Q % growth | 173.72M 21.50% | 188.76M 11.29% | 189.71M 28.14% | 196.29M 117.62% | 186.56M 7.39% | 204.55M 8.37% | 202.8M 6.90% | 208.28M 6.11% | 200.18M 7.30% | 219.63M 7.37% | 213.26M 5.16% | 217.02M 4.20% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 2.66 8.13% | 2.56 | 0.10 | 4.03% |
| Q3 2024 Q2Q % growth | 2.59 -4.78% | 2.45 | 0.14 | 5.70% |
| Q2 2024 Q2Q % growth | 2.80 4.09% | 2.42 | 0.38 | 15.80% |
| Q1 2024 Q2Q % growth | 2.27 -18.35% | 2.09 | 0.18 | 8.63% |
| Q4 2023 Q2Q % growth | 2.46 -17.45% | 2.43 | 0.03 | 1.38% |
| Q3 2023 Q2Q % growth | 2.72 3.42% | 2.39 | 0.33 | 13.71% |
| Q2 2023 Q2Q % growth | 2.69 -2.89% | 2.66 | 0.03 | 0.95% |
| Q1 2023 Q2Q % growth | 2.78 1.09% | 2.61 | 0.17 | 6.34% |
| Q4 2022 Q2Q % growth | 2.98 19.68% | 2.77 | 0.21 | 7.46% |
| Q3 2022 Q2Q % growth | 2.63 -2.59% | 2.52 | 0.11 | 4.37% |
| Q2 2022 Q2Q % growth | 2.77 6.13% | 2.76 | 0.01 | 0.30% |
| Q1 2022 Q2Q % growth | 2.75 8.70% | 2.74 | 0.01 | 0.26% |
| Q4 2021 Q2Q % growth | 2.49 4.18% | 2.46 | 0.03 | 1.35% |
| Q3 2021 Q2Q % growth | 2.70 15.88% | 2.60 | 0.10 | 3.70% |
| Q2 2021 Q2Q % growth | 2.61 65.19% | 2.40 | 0.21 | 8.57% |
| Q1 2021 Q2Q % growth | 2.53 37.50% | 2.21 | 0.32 | 14.27% |
| Q4 2020 Q2Q % growth | 2.39 18.91% | 2.13 | 0.26 | 12.40% |
| Q3 2020 Q2Q % growth | 2.33 37.87% | 1.82 | 0.51 | 28.20% |
| Q2 2020 Q2Q % growth | 1.58 -3.07% | 1.28 | 0.30 | 23.72% |
| Q1 2020 Q2Q % growth | 1.84 31.43% | 1.50 | 0.34 | 22.89% |
| Q4 2019 Q2Q % growth | 2.01 | 1.85 | 0.16 | 8.48% |
| Q3 2019 Q2Q % growth | 1.69 | 1.65 | 0.04 | 2.50% |
| Q2 2019 Q2Q % growth | 1.63 | 1.57 | 0.06 | 3.90% |
| Q1 2019 Q2Q % growth | 1.40 | 1.40 | 0.00 | 0.33% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 1.003B -1.08% | 993.46M | 9.089M | 0.91% |
| Q3 2024 Q2Q % growth | 1.01B -1.64% | 985.77M | 23.993M | 2.43% |
| Q2 2024 Q2Q % growth | 1.026B -3.19% | 1.035B | -8.883M | -0.86% |
| Q1 2024 Q2Q % growth | 1.012B -1.73% | 1.002B | 9.56M | 0.95% |
| Q4 2023 Q2Q % growth | 1.013B -7.85% | 1.001B | 12.476M | 1.25% |
| Q3 2023 Q2Q % growth | 1.027B 3.79% | 1.011B | 15.623M | 1.55% |
| Q2 2023 Q2Q % growth | 1.06B 8.92% | 1.064B | -4.063M | -0.38% |
| Q1 2023 Q2Q % growth | 1.029B 12.63% | 996.21M | 33.163M | 3.33% |
| Q4 2022 Q2Q % growth | 1.1B 21.52% | 1.045B | 54.843M | 5.25% |
| Q3 2022 Q2Q % growth | 989.157M 10.40% | 980.14M | 9.017M | 0.92% |
| Q2 2022 Q2Q % growth | 973.131M 6.40% | 1.005B | -31.869M | -3.17% |
| Q1 2022 Q2Q % growth | 913.929M 10.83% | 919.21M | -5.281M | -0.57% |
| Q4 2021 Q2Q % growth | 905.05M 14.42% | 897.16M | 7.89M | 0.88% |
| Q3 2021 Q2Q % growth | 895.937M 20.54% | 912.23M | -16.293M | -1.79% |
| Q2 2021 Q2Q % growth | 914.607M 33.99% | 889.25M | 25.357M | 2.85% |
| Q1 2021 Q2Q % growth | 824.6M 16.62% | 806.16M | 18.44M | 2.29% |
| Q4 2020 Q2Q % growth | 791M 14.46% | 764.43M | 26.57M | 3.48% |
| Q3 2020 Q2Q % growth | 743.3M 11.27% | 724.05M | 19.25M | 2.66% |
| Q2 2020 Q2Q % growth | 682.6M 3.80% | 645.71M | 36.89M | 5.71% |
| Q1 2020 Q2Q % growth | 707.1M 16.95% | 697.6M | 9.5M | 1.36% |
| Q4 2019 Q2Q % growth | 691.1M | 692.17M | -1.07M | -0.15% |
| Q3 2019 Q2Q % growth | 668M | 679.76M | -11.76M | -1.73% |
| Q2 2019 Q2Q % growth | 657.6M | 669.14M | -11.54M | -1.72% |
| Q1 2019 Q2Q % growth | 604.6M | 601.62M | 2.98M | 0.50% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -7.34% | -12% | -2.67% | -7.17% |
| Revenue | -1.79% | -4.69% | -2.78% | -4.52% |